Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wanish is a topical cream developed and marketed by Ozone Pharmaceuticals, primarily indicated for the reduction of stretch marks, scars, and skin blemishes. The formulation is a multi-ingredient combination of botanical extracts and vitamins, typically including *Aloe vera*, *Centella asiatica* (Gotu Kola), *Calendula officinalis*, wheat germ oil, almond oil, and *Vitamin E* (Tocopheryl acetate). It functions by promoting skin elasticity, enhancing collagen synthesis, and providing antioxidant protection to improve the texture and appearance of skin affected by pregnancy, weight fluctuations, or surgery. Wanish is positioned as a consumer pharmaceutical product within Ozone's portfolio and is widely available in the Indian market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wanish.